Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Spike mutation D614G alters SARS-CoV-2 fitness

Nature(2020)10.1038/s41586-020-2895-3Source: DataRank Database

Spike mutation D614G alters SARS-CoV-2 fitness is a research paper published in Nature (2020). On theSindex it has a DataRank of 18.5. It has been cited 1,768 times, with 200 citing works in its 1-hop citation network.

N/A

18.5DataRank · unranked

Scored on demand from live citation data

Open Access1,768 citations · 200 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)Impact (FWCI 37.48)OA: bronzeTopics (70)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 6%Citation Network 94%

Base Score Contribution

1.1

From this paper's citation signal

Citation Network Contribution

17.3

From 200 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 200 citers.

Emergence of a Highly Fit SARS-CoV-2 Variant
New England Journal of Medicine2020174 citations5 referencesContributes 1.033
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles
Proceedings of the National Academy of Sciences2022209 citations6 referencesContributes 0.891
Could new COVID variants undermine vaccines? Labs scramble to find out
Nature2021109 citations6 referencesContributes 0.783
SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity
The Lancet Infectious Diseases2021234 citations7 referencesContributes 0.780
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles
medRxiv202175 citations7 referencesContributes 0.619

Authors (22)

Yang Liu ORCID,Jianying Liu ORCID,Hongjie Xia ORCID,Bryan A. Johnson ORCID,Kumari G. Lokugamage

Live enrichment

PubMed:33106671 PMC:PMC8158177 OpenAlex:https://openalex.org/W3093768302

NIAID NIH HHS

Grant: R01 AI134907

NIAID NIH HHS

Grant: U19 AI142759

NIAID NIH HHS

Grant: UC7 AI094660

NCATS NIH HHS

Grant: UL1 TR001439

NIAID NIH HHS

Grant: R24 AI120942

NIAID NIH HHS

Grant: R43 AI145617

NIAID NIH HHS

Grant: R21 AI145400

NIAID NIH HHS

Grant: U01 AI151801

NCATS NIH HHS

Grant: TL1 TR001440

NIA NIH HHS

Grant: R00 AG049092

NIAID NIH HHS

Grant: R01 AI153602

National Institutes of Health

Grant: 5UL1TR001439-07

UTMB Clinical and Translational Science Award

National Institutes of Health

Grant: 5TL1TR001440-08

NRSA Training Core

National Institutes of Health

Grant: 5R24AI120942-05

World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)

National Institutes of Health

Grant: 5UC7AI094660-03

National Biocontainment Laboratories (NBLs) Operations Support

National Institutes of Health

Grant: 5U19AI142759-04

Antiviral Drug Discovery and Development Center (AD3C)

National Institutes of Health

Grant: 1R43AI145617-01A1

Discovery and Development of Broad-spectrum Protease Inhibitors of Flaviviruses of Significant Public Health Threats

National Institutes of Health

Grant: 3R01AI134907-03S2

A High-Throughput Platform for COVID-19 Serodiagnosis, Vaccine Evaluation, and Drug Discovery

National Institutes of Health

Grant: 5R01AI153602-03

Identifying host and viral correlates for coronavirus pathogenesis

FWCI

37.48

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: Springer TDM

journalhttps://www.nature.com/articles/s41586-020-2895-3.pdf

publisherhttps://www.nature.com/articles/s41586-020-2895-3.pdf

publisherhttps://www.nature.com/articles/s41586-020-2895-3

journalhttps://doi.org/10.1038/s41586-020-2895-3

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33106671

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies0301 basic medicine03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAnimalsDisease Models, AnimalCricetinaeHumansLungMaleMesocricetusModels, BiologicalMutationNasal MucosaNeutralization TestsTracheaVirionVirus ReplicationViral LoadTissue Culture TechniquesProtein StabilityGenetic FitnessAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

InfectivityVirologyVirusBiologyNeutralizationAntibodyViral entryViral replicationHamsterMutationCoronavirusViral loadNeutralizing antibodyImmunologyMedicineCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)DiseaseGeneGeneticsInternal medicineMolecular biologyMaleMultidisciplinaryCOVID-19 VaccinesMesocricetusProtein StabilitySARS-CoV-2COVID-19Antibodies, NeutralizingModels, BiologicalTissue Culture TechniquesTracheaDisease Models, AnimalNasal MucosaNeutralization TestsCricetinaeSpike Glycoprotein, CoronavirusAnimalsHumansGenetic FitnessLung

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being